Literature DB >> 12783392

Recurrent primary biliary cirrhosis.

James Neuberger1.   

Abstract

Liver transplantation remains the only effective treatment for end-stage primary biliary cirrhosis (PBC). It appears now well accepted that the disease recurs in the allograft. The diagnosis of recurrent PBC is made on the basis of a consistent history and demonstrating the histologic features of PBC on liver biopsy and exclusion of other causes of bile duct damage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783392     DOI: 10.1053/jlts.2003.50096

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  10 in total

Review 1.  Developments in liver transplantation.

Authors:  J Neuberger
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 2.  Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.

Authors:  Sarah Tischer; Robert J Fontana
Journal:  J Hepatol       Date:  2013-11-23       Impact factor: 25.083

3.  Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant.

Authors:  Jennifer E Guy; Peiqing Qian; Jeffrey A Lowell; Marion G Peters
Journal:  Liver Transpl       Date:  2005-10       Impact factor: 5.799

Review 4.  Primary biliary cirrhosis and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara
Journal:  Intractable Rare Dis Res       Date:  2012-05

Review 5.  Recurrent primary biliary cirrhosis after liver transplantation--the disease and its management.

Authors:  Ian Schreibman; Arie Regev
Journal:  MedGenMed       Date:  2006-05-03

Review 6.  Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?

Authors:  Daniel Smyk; Eirini I Rigopoulou; Yoh Zen; Robin Daniel Abeles; Charalambos Billinis; Albert Pares; Dimitrios P Bogdanos
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

Review 7.  Late liver function test abnormalities post-adult liver transplantation: a review of the etiology, investigation, and management.

Authors:  Oscar Mitchell; Arif M Cosar; Mohammad U Malik; Ahmet Gurakar
Journal:  Hepatol Int       Date:  2015-11-24       Impact factor: 6.047

8.  Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid.

Authors:  Sanjaya K Satapathy; Ollie D Jones; Jason M Vanatta; Faisal Kamal; Satish K Kedia; Yu Jiang; Satheesh P Nair; James D Eason
Journal:  Transplant Direct       Date:  2017-06-23

Review 9.  Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients.

Authors:  Maja Mijic; Ivona Saric; Bozena Delija; Milos Lalovac; Nikola Sobocan; Eva Radetic; Dora Martincevic; Tajana Filipec Kanizaj
Journal:  Can J Gastroenterol Hepatol       Date:  2022-07-22

Review 10.  Is there a role for cyclophilin inhibitors in the management of primary biliary cirrhosis?

Authors:  Shawn T Wasilenko; Aldo J Montano-Loza; Andrew L Mason
Journal:  Viruses       Date:  2013-01-24       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.